Royal Bank of Canada
TMO icon

Royal Bank of Canada’s Thermo Fisher Scientific TMO Stock Holding History

Quarter Market Value Status Shares Shares
Change %
Trade Value Portfolio Weight Portfolio Position
2025
Q2
$1.34B Buy
3,316,154
+91,478
+3% +$37.1M 0.24% 71
2025
Q1
$1.6B Sell
3,224,676
-47,855
-1% -$23.8M 0.34% 57
2024
Q4
$1.7B Buy
3,272,531
+26,287
+0.8% +$13.7M 0.34% 54
2024
Q3
$2.01B Sell
3,246,244
-31,543
-1% -$19.5M 0.41% 42
2024
Q2
$1.81B Buy
3,277,787
+94,822
+3% +$52.4M 0.41% 46
2024
Q1
$1.85B Sell
3,182,965
-61,408
-2% -$35.7M 0.42% 43
2023
Q4
$1.72B Sell
3,244,373
-1,351,086
-29% -$717M 0.4% 45
2023
Q3
$2.33B Sell
4,595,459
-130,918
-3% -$66.3M 0.63% 28
2023
Q2
$2.47B Buy
4,726,377
+1,829,301
+63% +$954M 0.65% 28
2023
Q1
$1.67B Buy
2,897,076
+212,706
+8% +$123M 0.47% 41
2022
Q4
$1.48B Buy
2,684,370
+143,749
+6% +$79.2M 0.42% 50
2022
Q3
$1.29B Buy
2,540,621
+178,556
+8% +$90.6M 0.41% 48
2022
Q2
$1.28B Sell
2,362,065
-119,371
-5% -$64.9M 0.38% 54
2022
Q1
$1.47B Sell
2,481,436
-24,158
-1% -$14.3M 0.37% 51
2021
Q4
$1.67B Buy
2,505,594
+51,474
+2% +$34.3M 0.38% 48
2021
Q3
$1.4B Sell
2,454,120
-98,123
-4% -$56.1M 0.37% 52
2021
Q2
$1.29B Sell
2,552,243
-14,751
-0.6% -$7.44M 0.34% 56
2021
Q1
$1.17B Buy
2,566,994
+130,247
+5% +$59.4M 0.34% 58
2020
Q4
$1.13B Sell
2,436,747
-130,521
-5% -$60.8M 0.33% 55
2020
Q3
$1.13B Buy
2,567,268
+171,288
+7% +$75.6M 0.4% 44
2020
Q2
$868M Buy
2,395,980
+87,406
+4% +$31.7M 0.34% 61
2020
Q1
$655M Sell
2,308,574
-32,470
-1% -$9.21M 0.32% 66
2019
Q4
$761M Sell
2,341,044
-149,982
-6% -$48.7M 0.27% 70
2019
Q3
$726M Buy
2,491,026
+187,367
+8% +$54.6M 0.29% 68
2019
Q2
$677M Buy
2,303,659
+75,814
+3% +$22.3M 0.27% 66
2019
Q1
$610M Buy
2,227,845
+95,739
+4% +$26.2M 0.26% 66
2018
Q4
$477M Buy
2,132,106
+12,743
+0.6% +$2.85M 0.23% 81
2018
Q3
$518M Buy
2,119,363
+39,290
+2% +$9.61M 0.22% 81
2018
Q2
$431M Buy
2,080,073
+68,342
+3% +$14.2M 0.19% 88
2018
Q1
$415M Buy
2,011,731
+30,355
+2% +$6.27M 0.19% 92
2017
Q4
$376M Buy
1,981,376
+1,840
+0.1% +$349K 0.17% 104
2017
Q3
$375M Buy
1,979,536
+68,816
+4% +$13M 0.18% 96
2017
Q2
$333M Buy
1,910,720
+16,187
+0.9% +$2.82M 0.17% 101
2017
Q1
$291M Buy
1,894,533
+114,486
+6% +$17.6M 0.16% 110
2016
Q4
$251M Buy
1,780,047
+253,702
+17% +$35.8M 0.14% 114
2016
Q3
$243M Sell
1,526,345
-197,978
-11% -$31.5M 0.14% 115
2016
Q2
$255M Buy
1,724,323
+59,909
+4% +$8.85M 0.15% 102
2016
Q1
$236M Buy
1,664,414
+28,314
+2% +$4.01M 0.15% 101
2015
Q4
$232M Buy
1,636,100
+934,111
+133% +$133M 0.15% 101
2015
Q3
$85.8M Buy
701,989
+470,499
+203% +$57.5M 0.06% 188
2015
Q2
$30M Sell
231,490
-95,178
-29% -$12.4M 0.02% 545
2015
Q1
$43.9M Buy
326,668
+65,389
+25% +$8.78M 0.03% 393
2014
Q4
$32.7M Buy
261,279
+57,126
+28% +$7.16M 0.02% 503
2014
Q3
$24.8M Buy
204,153
+23,767
+13% +$2.89M 0.02% 589
2014
Q2
$21.3M Sell
180,386
-348,986
-66% -$41.2M 0.01% 675
2014
Q1
$63.7M Buy
529,372
+33,650
+7% +$4.05M 0.05% 258
2013
Q4
$55.2M Buy
495,722
+356,979
+257% +$39.8M 0.04% 290
2013
Q3
$12.8M Sell
138,743
-17,970
-11% -$1.66M 0.01% 810
2013
Q2
$13.3M Buy
+156,713
New +$13.3M 0.01% 724